Quick Answer
Riboflavin Fatigue Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: The etiology of fatigue in IBD is multifactorial and may be associated with inflammation, anemia, nutrient deficiencies, medications, and microbiota.
Key Takeaways
- 01The etiology of fatigue in IBD is multifactorial and may be associated with inflammation, anemia, nutrient deficiencies, medications, and microbiota. [MORAIS Tayane (2026)]
- 02Fatigue in patients with IBD is associated with decreased physical functioning, mood disturbances, and low productivity, presenting symptoms of physical and mental exhaustion. [MORAIS Tayane (2026)]
- 03The guiding question for this study was: what is the current scientific evidence, over the last seven years, on the pharmacological treatment of fatigue in patients with IBD? [MORAIS Tayane (2026)]
- 04, , Inflammatory bowel disease (IBD) is a chronic inflammatory condition that results from the interaction between genetic and environmental factors that influence immune responses and one’s quality of life. [MORAIS Tayane (2026)]
The current Migaku evidence database contains 1 reusable source document for Riboflavin Fatigue Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- The etiology of fatigue in IBD is multifactorial and may be associated with inflammation, anemia, nutrient deficiencies, medications, and microbiota. [MORAIS Tayane (2026); evidence level 4]
- Fatigue in patients with IBD is associated with decreased physical functioning, mood disturbances, and low productivity, presenting symptoms of physical and mental exhaustion. [MORAIS Tayane (2026); evidence level 4]
- The guiding question for this study was: what is the current scientific evidence, over the last seven years, on the pharmacological treatment of fatigue in patients with IBD? [MORAIS Tayane (2026); evidence level 4]
- , , Inflammatory bowel disease (IBD) is a chronic inflammatory condition that results from the interaction between genetic and environmental factors that influence immune responses and one’s quality of life. [MORAIS Tayane (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources